Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Canagliflozin Market Growth 2022-2028

  • LP 4825945
  • 79 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Canagliflozin will have significant change from previous year. According to our (LP Information) latest study, the global Canagliflozin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Canagliflozin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Canagliflozin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Canagliflozin market, reaching US$ million by the year 2028. As for the Europe Canagliflozin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Canagliflozin players cover Janssen Pharmaceuticals, Mitsubishi Tanabe Pharma, Hansoh Pharma, and Hinye, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Canagliflozin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

100mg

300mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Diabetes

Heart Disease

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Janssen Pharmaceuticals

Mitsubishi Tanabe Pharma

Hansoh Pharma

Hinye

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Canagliflozin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Canagliflozin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Canagliflozin by Country/Region, 2017, 2022 & 2028

2.2 Canagliflozin Segment by Type

2.2.1 100mg

2.2.2 300mg

2.3 Canagliflozin Sales by Type

2.3.1 Global Canagliflozin Sales Market Share by Type (2017-2022)

2.3.2 Global Canagliflozin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Canagliflozin Sale Price by Type (2017-2022)

2.4 Canagliflozin Segment by Application

2.4.1 Diabetes

2.4.2 Heart Disease

2.4.3 Others

2.5 Canagliflozin Sales by Application

2.5.1 Global Canagliflozin Sale Market Share by Application (2017-2022)

2.5.2 Global Canagliflozin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Canagliflozin Sale Price by Application (2017-2022)

3 Global Canagliflozin by Company

3.1 Global Canagliflozin Breakdown Data by Company

3.1.1 Global Canagliflozin Annual Sales by Company (2020-2022)

3.1.2 Global Canagliflozin Sales Market Share by Company (2020-2022)

3.2 Global Canagliflozin Annual Revenue by Company (2020-2022)

3.2.1 Global Canagliflozin Revenue by Company (2020-2022)

3.2.2 Global Canagliflozin Revenue Market Share by Company (2020-2022)

3.3 Global Canagliflozin Sale Price by Company

3.4 Key Manufacturers Canagliflozin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Canagliflozin Product Location Distribution

3.4.2 Players Canagliflozin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Canagliflozin by Geographic Region

4.1 World Historic Canagliflozin Market Size by Geographic Region (2017-2022)

4.1.1 Global Canagliflozin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Canagliflozin Annual Revenue by Geographic Region

4.2 World Historic Canagliflozin Market Size by Country/Region (2017-2022)

4.2.1 Global Canagliflozin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Canagliflozin Annual Revenue by Country/Region

4.3 Americas Canagliflozin Sales Growth

4.4 APAC Canagliflozin Sales Growth

4.5 Europe Canagliflozin Sales Growth

4.6 Middle East & Africa Canagliflozin Sales Growth

5 Americas

5.1 Americas Canagliflozin Sales by Country

5.1.1 Americas Canagliflozin Sales by Country (2017-2022)

5.1.2 Americas Canagliflozin Revenue by Country (2017-2022)

5.2 Americas Canagliflozin Sales by Type

5.3 Americas Canagliflozin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Canagliflozin Sales by Region

6.1.1 APAC Canagliflozin Sales by Region (2017-2022)

6.1.2 APAC Canagliflozin Revenue by Region (2017-2022)

6.2 APAC Canagliflozin Sales by Type

6.3 APAC Canagliflozin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Canagliflozin by Country

7.1.1 Europe Canagliflozin Sales by Country (2017-2022)

7.1.2 Europe Canagliflozin Revenue by Country (2017-2022)

7.2 Europe Canagliflozin Sales by Type

7.3 Europe Canagliflozin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Canagliflozin by Country

8.1.1 Middle East & Africa Canagliflozin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Canagliflozin Revenue by Country (2017-2022)

8.2 Middle East & Africa Canagliflozin Sales by Type

8.3 Middle East & Africa Canagliflozin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Canagliflozin

10.3 Manufacturing Process Analysis of Canagliflozin

10.4 Industry Chain Structure of Canagliflozin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Canagliflozin Distributors

11.3 Canagliflozin Customer

12 World Forecast Review for Canagliflozin by Geographic Region

12.1 Global Canagliflozin Market Size Forecast by Region

12.1.1 Global Canagliflozin Forecast by Region (2023-2028)

12.1.2 Global Canagliflozin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Canagliflozin Forecast by Type

12.7 Global Canagliflozin Forecast by Application

13 Key Players Analysis

13.1 Janssen Pharmaceuticals

13.1.1 Janssen Pharmaceuticals Company Information

13.1.2 Janssen Pharmaceuticals Canagliflozin Product Offered

13.1.3 Janssen Pharmaceuticals Canagliflozin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Janssen Pharmaceuticals Main Business Overview

13.1.5 Janssen Pharmaceuticals Latest Developments

13.2 Mitsubishi Tanabe Pharma

13.2.1 Mitsubishi Tanabe Pharma Company Information

13.2.2 Mitsubishi Tanabe Pharma Canagliflozin Product Offered

13.2.3 Mitsubishi Tanabe Pharma Canagliflozin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Mitsubishi Tanabe Pharma Main Business Overview

13.2.5 Mitsubishi Tanabe Pharma Latest Developments

13.3 Hansoh Pharma

13.3.1 Hansoh Pharma Company Information

13.3.2 Hansoh Pharma Canagliflozin Product Offered

13.3.3 Hansoh Pharma Canagliflozin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Hansoh Pharma Main Business Overview

13.3.5 Hansoh Pharma Latest Developments

13.4 Hinye

13.4.1 Hinye Company Information

13.4.2 Hinye Canagliflozin Product Offered

13.4.3 Hinye Canagliflozin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Hinye Main Business Overview

13.4.5 Hinye Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Canagliflozin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Canagliflozin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 100mg

Table 4. Major Players of 300mg

Table 5. Global Canagliflozin Sales by Type (2017-2022) & (K Units)

Table 6. Global Canagliflozin Sales Market Share by Type (2017-2022)

Table 7. Global Canagliflozin Revenue by Type (2017-2022) & ($ million)

Table 8. Global Canagliflozin Revenue Market Share by Type (2017-2022)

Table 9. Global Canagliflozin Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Canagliflozin Sales by Application (2017-2022) & (K Units)

Table 11. Global Canagliflozin Sales Market Share by Application (2017-2022)

Table 12. Global Canagliflozin Revenue by Application (2017-2022)

Table 13. Global Canagliflozin Revenue Market Share by Application (2017-2022)

Table 14. Global Canagliflozin Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Canagliflozin Sales by Company (2020-2022) & (K Units)

Table 16. Global Canagliflozin Sales Market Share by Company (2020-2022)

Table 17. Global Canagliflozin Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Canagliflozin Revenue Market Share by Company (2020-2022)

Table 19. Global Canagliflozin Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Canagliflozin Producing Area Distribution and Sales Area

Table 21. Players Canagliflozin Products Offered

Table 22. Canagliflozin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Canagliflozin Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Canagliflozin Sales Market Share Geographic Region (2017-2022)

Table 27. Global Canagliflozin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Canagliflozin Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Canagliflozin Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Canagliflozin Sales Market Share by Country/Region (2017-2022)

Table 31. Global Canagliflozin Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Canagliflozin Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Canagliflozin Sales by Country (2017-2022) & (K Units)

Table 34. Americas Canagliflozin Sales Market Share by Country (2017-2022)

Table 35. Americas Canagliflozin Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Canagliflozin Revenue Market Share by Country (2017-2022)

Table 37. Americas Canagliflozin Sales by Type (2017-2022) & (K Units)

Table 38. Americas Canagliflozin Sales Market Share by Type (2017-2022)

Table 39. Americas Canagliflozin Sales by Application (2017-2022) & (K Units)

Table 40. Americas Canagliflozin Sales Market Share by Application (2017-2022)

Table 41. APAC Canagliflozin Sales by Region (2017-2022) & (K Units)

Table 42. APAC Canagliflozin Sales Market Share by Region (2017-2022)

Table 43. APAC Canagliflozin Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Canagliflozin Revenue Market Share by Region (2017-2022)

Table 45. APAC Canagliflozin Sales by Type (2017-2022) & (K Units)

Table 46. APAC Canagliflozin Sales Market Share by Type (2017-2022)

Table 47. APAC Canagliflozin Sales by Application (2017-2022) & (K Units)

Table 48. APAC Canagliflozin Sales Market Share by Application (2017-2022)

Table 49. Europe Canagliflozin Sales by Country (2017-2022) & (K Units)

Table 50. Europe Canagliflozin Sales Market Share by Country (2017-2022)

Table 51. Europe Canagliflozin Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Canagliflozin Revenue Market Share by Country (2017-2022)

Table 53. Europe Canagliflozin Sales by Type (2017-2022) & (K Units)

Table 54. Europe Canagliflozin Sales Market Share by Type (2017-2022)

Table 55. Europe Canagliflozin Sales by Application (2017-2022) & (K Units)

Table 56. Europe Canagliflozin Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Canagliflozin Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Canagliflozin Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Canagliflozin Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Canagliflozin Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Canagliflozin Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Canagliflozin Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Canagliflozin Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Canagliflozin Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Canagliflozin

Table 66. Key Market Challenges & Risks of Canagliflozin

Table 67. Key Industry Trends of Canagliflozin

Table 68. Canagliflozin Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Canagliflozin Distributors List

Table 71. Canagliflozin Customer List

Table 72. Global Canagliflozin Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Canagliflozin Sales Market Forecast by Region

Table 74. Global Canagliflozin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Canagliflozin Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Canagliflozin Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Canagliflozin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Canagliflozin Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Canagliflozin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Canagliflozin Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Canagliflozin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Canagliflozin Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Canagliflozin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Canagliflozin Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Canagliflozin Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Canagliflozin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Canagliflozin Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Canagliflozin Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Canagliflozin Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Canagliflozin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Canagliflozin Revenue Market Share Forecast by Application (2023-2028)

Table 92. Janssen Pharmaceuticals Basic Information, Canagliflozin Manufacturing Base, Sales Area and Its Competitors

Table 93. Janssen Pharmaceuticals Canagliflozin Product Offered

Table 94. Janssen Pharmaceuticals Canagliflozin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Janssen Pharmaceuticals Main Business

Table 96. Janssen Pharmaceuticals Latest Developments

Table 97. Mitsubishi Tanabe Pharma Basic Information, Canagliflozin Manufacturing Base, Sales Area and Its Competitors

Table 98. Mitsubishi Tanabe Pharma Canagliflozin Product Offered

Table 99. Mitsubishi Tanabe Pharma Canagliflozin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Mitsubishi Tanabe Pharma Main Business

Table 101. Mitsubishi Tanabe Pharma Latest Developments

Table 102. Hansoh Pharma Basic Information, Canagliflozin Manufacturing Base, Sales Area and Its Competitors

Table 103. Hansoh Pharma Canagliflozin Product Offered

Table 104. Hansoh Pharma Canagliflozin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Hansoh Pharma Main Business

Table 106. Hansoh Pharma Latest Developments

Table 107. Hinye Basic Information, Canagliflozin Manufacturing Base, Sales Area and Its Competitors

Table 108. Hinye Canagliflozin Product Offered

Table 109. Hinye Canagliflozin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Hinye Main Business

Table 111. Hinye Latest Developments

List of Figures

Figure 1. Picture of Canagliflozin

Figure 2. Canagliflozin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Canagliflozin Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Canagliflozin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Canagliflozin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 100mg

Figure 10. Product Picture of 300mg

Figure 11. Global Canagliflozin Sales Market Share by Type in 2021

Figure 12. Global Canagliflozin Revenue Market Share by Type (2017-2022)

Figure 13. Canagliflozin Consumed in Diabetes

Figure 14. Global Canagliflozin Market: Diabetes (2017-2022) & (K Units)

Figure 15. Canagliflozin Consumed in Heart Disease

Figure 16. Global Canagliflozin Market: Heart Disease (2017-2022) & (K Units)

Figure 17. Canagliflozin Consumed in Others

Figure 18. Global Canagliflozin Market: Others (2017-2022) & (K Units)

Figure 19. Global Canagliflozin Sales Market Share by Application (2017-2022)

Figure 20. Global Canagliflozin Revenue Market Share by Application in 2021

Figure 21. Canagliflozin Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Canagliflozin Revenue Market Share by Company in 2021

Figure 23. Global Canagliflozin Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Canagliflozin Revenue Market Share by Geographic Region in 2021

Figure 25. Global Canagliflozin Sales Market Share by Region (2017-2022)

Figure 26. Global Canagliflozin Revenue Market Share by Country/Region in 2021

Figure 27. Americas Canagliflozin Sales 2017-2022 (K Units)

Figure 28. Americas Canagliflozin Revenue 2017-2022 ($ Millions)

Figure 29. APAC Canagliflozin Sales 2017-2022 (K Units)

Figure 30. APAC Canagliflozin Revenue 2017-2022 ($ Millions)

Figure 31. Europe Canagliflozin Sales 2017-2022 (K Units)

Figure 32. Europe Canagliflozin Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Canagliflozin Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Canagliflozin Revenue 2017-2022 ($ Millions)

Figure 35. Americas Canagliflozin Sales Market Share by Country in 2021

Figure 36. Americas Canagliflozin Revenue Market Share by Country in 2021

Figure 37. United States Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Canagliflozin Sales Market Share by Region in 2021

Figure 42. APAC Canagliflozin Revenue Market Share by Regions in 2021

Figure 43. China Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Canagliflozin Sales Market Share by Country in 2021

Figure 50. Europe Canagliflozin Revenue Market Share by Country in 2021

Figure 51. Germany Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Canagliflozin Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Canagliflozin Revenue Market Share by Country in 2021

Figure 58. Egypt Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Canagliflozin Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Canagliflozin in 2021

Figure 64. Manufacturing Process Analysis of Canagliflozin

Figure 65. Industry Chain Structure of Canagliflozin

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390